Jurinko v. Medical Protective Co.

Opinions of the United
2008 Decisions States Court of Appeals
for the Third Circuit

12-24-2008

Jurinko v. Med Protective Co
Precedential or Non-Precedential: Non-Precedential

Docket No. 06-3519

Follow this and additional works at: http://digitalcommons.law.villanova.edu/thirdcircuit_2008

Recommended Citation
"Jurinko v. Med Protective Co" (2008). 2008 Decisions. Paper 46.
http://digitalcommons.law.villanova.edu/thirdcircuit_2008/46

This decision is brought to you for free and open access by the Opinions of the United States Court of Appeals for the Third Circuit at Villanova
University School of Law Digital Repository. It has been accepted for inclusion in 2008 Decisions by an authorized administrator of Villanova
University School of Law Digital Repository. For more information, please contact Benjamin.Carlson@law.villanova.edu.
 NOT PRECEDENTIAL

UNITED STATES COURT OF APPEALS
FOR THE THIRD CIRCUIT

Nos. 06-3519 & 06-3666

STEPHEN P. JURINKO; CYNTHIA JURINKO, H/W
as assignees of Paul G. Marcincin,

v.

THE MEDICAL PROTECTIVE COMPANY;
MEDICAL CARE AVAILABILITY AND
REDUCTION OF ERROR FUND,
Successor in interest to or formerly known as
Medical Professional Liability Catastrophe Loss Fund

Medical Protective Company, Appellant at 06-3519
Stephen P. Jurinko; Cynthia Jurinko, Appellants in 06-3666

On Appeal from the United States District Court
for the Eastern District of Pennsylvania
D.C. Civil Action No. 03-cv-04053
(District Judge: Honorable Cynthia M. Rufe)

Argued January 17, 2008

Before: SCIRICA, Chief Judge, BARRY* and ROTH, Circuit Judges.

(Filed: December 24, 2008)

*
The Honorable Maryanne Trump Barry participated in the oral argument but
discovered facts causing her to recuse from this matter prior to filing of the Opinion. The
remaining judges are unanimous in this decision, and this Opinion and Judgment are
therefore being filed by a quorum of the panel.
JAMES C. SARGENT, JR., ESQUIRE (ARGUED)
Lamb McErlane
24 East Market Street
P.O. Box 565
West Chester, Pennsylvania 19381

JEFFREY R. LERMAN, ESQUIRE
GLENN F. ROSENBLUM, ESQUIRE
Montgomery, McCracken, Walker & Rhoads
123 South Broad Street, 24th Floor
Philadelphia, Pennsylvania 19109
Attorneys for Appellant/Cross-Appellee,
The Medical Protective Company

MARK W. TANNER, ESQUIRE (ARGUED)
Feldman, Shepherd, Wohlgelernter, Tanner & Weinstock
1845 Walnut Street, 25th Floor
Philadelphia, Pennsylvania 19103

MARK B. FROST, ESQUIRE
Frost & Zeff
Pier 5 at Penn's Landing, 2nd Floor
7 North Christopher Columbus Boulevard
Philadelphia, Pennsylvania 19106
Attorneys for Appellees/Cross-Appellants,
Stephen P. Jurinko and Cynthia Jurinko, H/W
as assignees of Paul G. Marcincin

OPINION OF THE COURT

SCIRICA, Chief Judge.

Plaintiffs Stephen and Cynthia Jurinko brought a diversity action in federal court

alleging bad faith on the part of an insurer, The Medical Protective Company, in a

medical malpractice suit Mr. Jurinko brought in state court against Medical Protective’s

2
insured, Dr. Paul Marcincin. A state jury found Dr. Marcincin liable for medical

malpractice and awarded Mr. Jurinko $2.5 million in damages, $1.3 million more than Dr.

Marcincin’s coverage. In lieu of paying the excess verdict, Dr. Marcincin assigned to the

Jurinkos his bad faith claim against Medical Protective for its conduct in the malpractice

action.

A federal jury found Medical Protective acted in bad faith and awarded the

Jurinkos compensatory and punitive damages, in the amounts of $1,658,345 and

$6,250,000 respectively. The District Court denied Medical Protective’s post-trial

motions seeking reversal of the jury verdict and a new trial, and then granted in part and

denied in part the Jurinkos’ motion to mold the verdict, awarding attorneys’ fees, costs,

and interest. Both parties have appealed. We will affirm in part, but will reduce the

amount of punitive damages awarded.

I.

A.

On July 24, 1992, Stephen Jurinko visited Dr. Paul Marcincin, a dermatologist, at

his office in Bethlehem, Pennsylvania. Jurinko had a dark spot on his nose, which Dr.

Marcincin treated topically. In 1993, the spot returned, and Jurinko visited Dr. Marcincin

again. Dr. Marcincin took a shaved biopsy, which he sent to the SmithKline Beecham

Laboratory for pathology analysis. Dr. Andrew S. Edelman, a SmithKline pathologist,

reviewed the sample and issued a report that found no cancer cells but explained that the

sample was insufficient to rule out cancer. A portion of the skin from Jurinko’s nose —

3
the base of the epithelium — was not included in the sample. Without it, Dr. Edelman

could not conclusively rule out cancer. Despite Dr. Edelman’s report explicitly finding

the results inconclusive, Dr. Marcincin interpreted the report as ruling out cancer and did

not follow up on the missing portion of the sample.

On July 21, 1999, Jurinko again saw Dr. Marcincin because the spot had returned.

Dr. Marcincin removed the spot. But in April 2000, Jurinko discovered a lump on his

neck. A biopsy revealed it was a lymphatic malignant tumor. Jurinko notified Dr.

Marcincin, who contacted SmithKline, requesting the 1993 sample be retested. After

reviewing the 1993 sample, SmithKline pathologists detected cancer cells.

B.

Jurinko filed suit against Dr. Marcincin, Dr. Edelman, and SmithKline. Both Dr.

Edelman and Dr. Marcincin had primary malpractice coverage through Medical

Protective and statutory excess coverage through the CAT/MCARE Fund.1 Medical

Protective provided Dr. Marcincin with $200,000 in primary coverage, and the CAT Fund

provided $1 million in excess coverage.

Because Medical Protective insured both Dr. Marcincin and Dr. Edelman, Medical

Protective was obligated to appoint counsel for each physician. Nevertheless, Medical

Protective’s claims adjuster, James Alff, appointed only one attorney, James Kilcoyne, to

1
The CAT Fund refers to the “Medical Professional Liability Catastrophic Loss Fund.”
The CAT Fund became the “Medical Care Availability and Reduction of Error Fund,” or
MCARE Fund, during the course of these events. For relevant purposes here the CAT
and MCARE funds are the same.

4
represent both physicians despite knowing this created a conflict of interest in violation of

the Pennsylvania Rules of Professional Conduct. Kilcoyne filed an answer to the

complaint on Dr. Edelman’s behalf. Kilcoyne represented Dr. Edelman from September

2000 through May 15, 2001, when Kilcoyne withdrew his appearance. Kilcoyne

continued to represent Dr. Marcincin for the remainder of the state court litigation.

For its part, the CAT Fund determined it was required to provide primary coverage

for Dr. Edelman because the suit was commenced more than four years after the alleged

misdiagnosis.2 Once the CAT Fund accepted Dr. Edelman’s defense, it appointed attorney

Jack Snyder to represent him.

In December 2001, Mr. Jurinko’s attorney, Mark Frost, demanded $4 million but

the defendants refused to settle. In a January 2002 post-discovery and pre-trial settlement

conference, Court of Common Pleas Judge Sandra Mazer Moss recommended an amount

between $1.5 and $2 million.3 Post-conference, Frost made a new settlement demand of

$2 million, which defendants rejected without making a counter-offer. Judge Moss held

another conference, which Dr. Marcincin attended. After the conference Dr. Marcincin

2
40 Pa. Stat. Ann. § 1301.605 provides:
In the event that any claim is made against a health care provider subject to
the provisions of Article VII more than four years after the breach of
contract or tort occurred which is filed within the statute of limitations, such
claim shall be defended and paid by the [CAT] Fund.
3
At the time of the settlement conference, there were three defendants in the case: Dr.
Marcincin, SmithKline, and Dr. Edelman. Judge Moss recommended each party provide
equal contributions.

5
informed Kilcoyne, in writing, that he wanted to settle. Kilcoyne told Alff, Medical

Protective’s claims adjuster, the case should be settled. He explained to Alff that Dr.

Parrish, one of the experts to be called on Dr. Marcincin’s behalf, told him that Dr.

Marcincin’s “notes were terrible, and could be problematic at the time of trial.” There was

also a concern that the jury would be confused by the case’s medical complexities.

Despite these concerns, Alff made no further attempt to settle prior to trial.

In April 2002, the case was tried before a jury in the Philadelphia Court of

Common Pleas, Judge Alfred DiBona presiding. Judge DiBona also recommended

settlement, in the amount of $1.6 million. On April 5, the CAT Fund wrote Medical

Protective, requesting it tender its policy. The letter stated:

As we have discussed, it is the [CAT] Fund’s position that Dr. Marcincin’s
exposure in this matter exceeds his primary limits, thus a full tender from
The Medical Protective Company on his behalf is warranted. Offering
anything less than a tender on behalf of Dr. Marcincin is in bad faith and will
adversely affect a global effort to settle this case.

Because the CAT Fund was Dr. Marcincin’s excess insurer it could not offer any of its $1

million in a settlement until Medical Protective, the primary insurer, tendered its policy.

But Alff responded that Medical Protective would neither offer the policy limits nor offer

more than $50,000.

Pre-trial, the defendants offered a settlement of $650,000, with Medical Protective

still only willing to contribute $50,000,4 which Jurinko did not accept. During trial,

4
SmithKline and the CAT Fund would have each contributed $300,000. While the
(continued...)

6
SmithKline entered into a joint tortfeasor settlement agreement with Jurinko. Only after

the trial and verdict did Medical Protective learn SmithKline had paid $525,000 in

settlement.

After SmithKline settled, the CAT Fund’s counsel, Jack Snyder, discussed with

Kilcoyne the possibility of making a settlement offer of $650,000. The CAT Fund would

have offered $500,000 on behalf of Dr. Edelman. Snyder asked Kilcoyne if Medical

Protective would offer $150,000 on behalf of Dr. Marcincin. Kilcoyne discussed this

possibility with Alff, but Medical Protective never offered more than $50,000.

During trial and after Smithkline settled, Jurinko made a final settlement demand on

Dr. Edelman and Dr. Marcincin of $1.1 million. Medical Protective refused to settle at

this amount and determined the case would likely go to verdict. Kilcoyne believed an

adverse verdict would likely be between $750,000 and $1 million. In his notes, Alff wrote

that he thought the case was worth $750,000, but would likely settle for $1 million. Frost

had authority from Jurinko to accept $1 million. But Alff resolved to “hold tight [at

$50,000] and see how this plays out.”

4
(...continued)
CAT Fund was Dr. Marcincin’s excess insurer, any money contributed was on behalf of
Dr. Edelman, as his primary insurer. As noted the CAT Fund, as Dr. Marcincin’s excess
insurer, was incapable of offering any money on behalf of Dr. Marcincin until Medical
Protective offered its policy limits.

7
 After Frost made the $1.1 million demand, no more demands or offers were made,

and the case went to verdict. The jury returned a verdict exonerating Dr. Edelman and

finding Dr. Marcincin liable for $2.5 million, $1.3 million above his coverage.

C.

After trial, Dr. Marcincin assigned to Stephen and Cynthia Jurinko the right to

pursue a bad faith claim against Medical Protective in exchange for a release of the excess

verdict amount. As noted, the Jurinkos brought suit in federal court, alleging Medical

Protective acted in bad faith by appointing Kilcoyne to represent both physicians and by

failing to settle the case within policy limits.

Pre-trial, Medical Protective sought to exclude the testimony of attorney James

Griffith, the Jurinkos’ expert witness, contending his report offered improper opinions on

whether Medical Protective acted in bad faith. Griffith was an attorney with great

experience defending physicians in medical malpractice cases. The District Court denied

the motion. At trial, Griffith testified that “there [was] an inherent conflict right there on

the face of the [complaint]” because it alleged Dr. Marcincin was negligent in his

treatment and Dr. Edelman was negligent in misreading the slide.” He testified the

conflict prevented Kilcoyne from mounting a defense that blamed Dr. Edelman and from

filing a cross-claim against Dr. Edelman. In Griffith’s professional judgment, Medical

Protective behaved unreasonably by refusing to tender the policy after multiple judges set

a settlement amount above $1.5 million and Dr. Marcincin had consented to settle, and by

8
failing to increase its offer above $50,000. Griffin said Medical Protective’s conduct

caused Dr. Marcincin to suffer an adverse verdict.

Medical Protective’s expert witness, attorney Jack Hartman, testified that Medical

Protective reasonably evaluated the case and reasonably managed the settlement

discussions. Hartman believed the testimony in the bad faith case demonstrated Dr.

Marcincin had reasonably relied on Dr. Edelman, and that the cancer in Jurinko’s nose did

not cause the cancer on his neck. He said Dr. Edelman was the “target defendant,” and

therefore Medical Protective’s offer reflected the relative apportionment of damages. He

also said, because the CAT Fund was a “much bigger player,” having $1 million in

coverage for Dr. Edelman, and $1 million in excess coverage for Dr. Marcincin, Medical

Protective reasonably “follow[ed] the CAT Fund’s lead.”

Alff’s testimony was particularly damaging to Medical Protective. He testified that

he acted unreasonably and irresponsibly in settlement negotiations,5 and that he denied Dr.

5
Mark Tanner, the Jurinkos’ attorney in the bad faith case, examined Alff with regard
to settlement negotiations:
Q [Tanner]: [W]hat you were doing, is you were trying to play a negotiating tactic against
the CAT Fund, weren’t you?
A [Alff]: Yes.
Q: What you were really doing is you were trying to hold on to a little bit of Medical
Protective’s money, because what you wanted to do was sort of scare the CAT Fund into
paying extra money on behalf of Dr. [Edelman] to try and settle the whole case, right?
A: That’s correct.
...
Q: In other words, even though Dr. Marcincin had exposure and had insurance, you
thought well, if I don’t pay it and I’m really unreasonable, then maybe the CAT Fund will
just throw more money in on behalf of [Edelman] and I can save my money, isn’t that
(continued...)

9
Marcincin an effective defense by appointing Kilcoyne to represent both physicians and by

allowing Kilcoyne to continue representing Dr. Marcincin at trial.6 But Kilcoyne testified

5
(...continued)
right?
A: Yes.
...
Q: [I]f your insured, Dr. Marcincin has exposure, and his exposure exceeds $50,000, is it
right, is it consistent with your understanding that somebody else should pay for his
exposure, like Dr. [Edelman] and his line of coverage, just because you’re being
unreasonable?
A: No, that’s not fair.
Q: But that’s what was going on, isn’t it?
A: It is.
...
Q: And in fairness, looking back, you did not do everything you certainly could to protect
the interests of Dr. Marcincin, did you?
A: No.
6
Alff testified about the conflict and acknowledged he knew Kilcoyne’s representation
would deprive Dr. Marcincin of a defense and cross-claim.
Q[Mark Tanner, Jurinko’s attorney]: [Y]ou were aware of [ethical rules prohibiting
clients with adverse interests] when you made the decision to tell Jim Kilcoyne to
represent Dr. Marcincin and Dr. Edelman, true?
A[Alff]: True.
...
Q: And because Dr. Marcincin over here never got a new lawyer, unlike Dr. Edelman, Dr.
Marcincin couldn’t say hey, it’s Dr. Edelman’s fault, I want to go after him, he’s the one
who should be responsible, true?
A: True.
Q: So, from the earliest moment in the case, your decision to appoint the same lawyer,
Jim Kilcoyne, for both Dr. Marcincin and Dr. Edelman, prevented forever Dr. Marcincin
from asserting a defense in this case that, hey, it’s not my fault, it’s Dr. Edelman’s fault,
true?
A: True.
Q: And you deprived him of that defense within the first [moment] of this claim, correct?
A: Correct.
Q: And you never took any steps such as to get him a knew lawyer that would give him
(continued...)

10
that his representation of both physicians did not create a conflict of interest because he

was not prevented from arguing at trial that Dr. Marcincin relied on Dr. Edelman’s report.7

The jury also heard from Dr. Marcincin, Stephen Jurinko, Frost, and two representatives of

the CAT Fund.

Both parties submitted jury instructions. The District Court instructed the jury

according to Pennsylvania Suggested Standard Civil Jury Instructions § 13.21:

Failure to offer policy limits does not evidence bad faith where there is no
possibility of settlement within the policy limits. There must be an
expressed willingness on the part of the third party, the plaintiff in the
underlying litigation, at some point in time to accept an offer of the policy
limits.

Issuing a general verdict, the jury found for the Jurinkos and returned a verdict of

$1,658,345 in compensatory damages and $6,250,000 in punitive damages.

After trial, Medical Protective brought motions renewing its motion for judgment as

a matter of law, or in the alternative, for a new trial. Medical Protective argued: (1) the

verdict was not supported by adequate evidence that the case would have settled had

Medical Protective tendered its policy limits; (2) evidence of Medical Protective’s

6
(...continued)
that defense back, isn’t that right?
A: That’s right.
7
Kilcoyne testified that, while he served as Dr. Edelman’s attorney for eight months
and filed an answer to Jurinko’s complaint on Dr. Edelman’s behalf, he did not enter into
a confidential attorney-client relationship. He said, “[f]or purposes of getting the case
where it should be, [Dr. Edelman] called me on the phone, we talked about it briefly. [Dr.
Edelman] was acceptable with it. I told him he was going to get a new attorney shortly.”

11
assignment of Kilcoyne as attorney for Dr. Edelman and Dr. Marcincin was improperly

admitted; (3) the amount of punitive damages awarded was excessive and violated due

process; (4) the court incorrectly charged the jury with respect to punitive damages; and

(5) the judgment erroneously permitted duplicative interest and delay damages.

The District Court denied Medical Protective’s motions. The court found the

Jurinkos presented sufficient evidence for the jury to find bad faith. Additionally, the

Court found Griffith’s expert testimony was relevant to the central issues of the trial and

therefore properly admitted. It found “it was proper and relevant for Mr. Griffith to

provide an opinion as to the ethics of this dual representation, the likely impact on Dr.

Marcincin’s defense, and whether this action constituted bad faith on the part of Medical

Protective.” It also found the jury was properly instructed on punitive damages and

properly awarded punitive damages, and that the award, with a ratio of less than 4:1, was

not unconstitutionally excessive.

Medical Protective filed a motion for reconsideration of the post-trial motion for

judgment as a matter of law, which the District Court denied. The Jurinkos filed a motion

to mold the verdict to reflect an award of attorneys’ fees, litigation expenses, and statutory

interest pursuant to 42 Pa. Cons. Stat. § 8371. The District Court awarded attorneys’ fees,

finding the award was necessary to make the plaintiffs whole. The Jurinkos urged the

court to use the percentage-of-recovery method to calculate attorneys’ fees, but the District

Court found the lodestar method applied because Pennsylvania Rule of Civil Procedure

1716 requires it, and because no court had ever adopted the percentage-of-recovery

12
method in a bad faith case. After applying the lodestar method, the District Court awarded

$323,167.50 in attorneys’ fees. The court also assessed $15,438.06 in costs, and awarded

additional interest at the rate of prime plus three percent. The Jurinkos contended that, in

addition to post-verdict interest, they should be awarded $432,482 in statutory interest

under 42 Pa. Con. Stat. § 8371. The District Court rejected this argument, finding the

parties had stipulated to an award of interest during trial. The additional awards produced

a total verdict of $8,246,950.56, plus interest.8

8
The District Court had subject matter jurisdiction under 28 U.S.C. § 1332. We have
jurisdiction under 28 U.S.C. § 1291. Issues involving bad faith are governed by
Pennsylvania law. See Erie R.R. Co. v. Tompkins, 304 U.S. 64, 78 (1938). Our review of
the District Court’s interpretation and application of bad faith insurance law is plenary.
Coleman v. Kaye, 87 F.3d 1491, 1497 (3d Cir. 1996). We exercise plenary review over
orders granting judgment as a matter of law and apply the same standard as the District
Court:
A motion for judgment as a matter of law under Federal Rule 50(a) should
be granted only if, viewing the evidence in the light most favorable to the
nonmoving party, there is no question of material fact for the jury and any
verdict other than the one directed would be erroneous under the governing
law.
Beck v. City of Pittsburgh, 89 F.3d 966, 971 (3d Cir. 1996) (internal quotations omitted).
Our review of the District Court’s decision upholding the constitutionality of the
amount of punitive damages award is de novo. Cooper Indus., Inc. v. Leatherman Tool
Group, Inc., 532 U.S. 424, 431, 436 (2001). We must “engage[] in an independent
examination of the relevant criteria,” id. at 435, “to determine whether the punitive
damage award is so ‘grossly disproportional’ to the defendant’s conduct as to amount to a
constitutional violation,” Willow Inn, Inc. v. Pub. Serv. Mut. Ins. Co., 399 F.3d 224, 230
(3d Cir. 2005) (quoting Cooper Indus., 532 U.S. at 434). We review the reasonableness
of the District Court’s award of attorneys’ fees for abuse of discretion, Rode v.
Dellarciprete, 892 F.2d 1177, 1182 (3d Cir. 1990), unless the question is whether the
court applied the correct standard, in which case our review is plenary, Bd. of Trs. of
Trucking Employees of North Jersey Welfare Fund, Inc. v. Centra, 983 F.2d 495, 508 (3d
Cir. 1992).

13
 II.

Medical Protective contests the jury’s finding of bad faith. It contends the evidence

is insufficient to support a finding of bad faith for failure to settle; and with respect to bad

faith in the representation of Dr. Marcincin, it contends the testimony of Plaintiffs’ expert,

Griffith, about the conflict of interest was irrelevant or otherwise legally insufficient.

A. Bad Faith Failure to Settle

Medical Protective contends the evidence did not support liability for a bad faith

failure to settle. Pennsylvania has long recognized a contractual cause of action for bad

faith conduct on the part of an insurer. Cowden v. Aetna Cas. & Sur. Co., 134 A.2d 223,

229 (Pa. 1957). Pennsylvania also provides a statutory remedy, which permits an insured

to recover interest, punitive damages, court costs, and attorneys’ fees. 42 Pa. Cons. Stat. §

8371.9 Section 8371 does not define “bad faith,” but Pennsylvania courts and our court

have recognized the “universally acknowledged meaning”:

“Bad faith” on part of insurer is any frivolous or unfounded refusal to pay
proceeds of a policy; it is not necessary that such refusal be fraudulent. For
purposes of an action against an insurer for failure to pay a claim, such

9
The statute provides:
In an action arising under an insurance policy, if the court finds that the
insurer has acted in bad faith toward the insured, the court may take all of
the following actions:
(1) Award interest on the amount of the claim from the date the claim was
made by the insured in an amount equal to the prime rate of interest plus
3%.
(2) Award punitive damages against the insurer.
(3) Assess court costs and attorney fees against the insurer.
42 Pa. Cons. Stat. § 8371 (2006).

14
 conduct imports a dishonest purpose and means a breach of a known duty
(i.e., good faith and fair dealing), through some motive of self-interest or ill
will; mere negligence or bad judgment is not bad faith.

Polselli v. Nationwide Mut. Fire Ins. Co., 23 F.3d 747, 751 (3d Cir. 1994) (quoting

Black’s Law Dictionary 139 (6th ed. 1990)). We have adopted the test the Pennsylvania

Superior Court enunciated in Terletsky v. Prudential Prop. & Cas. Ins. Co., 649 A.2d 680

(Pa. Super. Ct. 1994), which requires a plaintiff, to recover under § 8371, to show by clear

and convincing evidence that the insurer: “(1) did not have a reasonable basis for denying

benefits under the policy; and (2) knew or recklessly disregarded its lack of a reasonable

basis in denying the claim.” J.C. Penney Life Ins. Co. v. Pilosi, 393 F.3d 356, 367 (3d Cir.

2004) (citations omitted); Terletsky, 649 A.2d at 688. “[T]he motive of self-interest or ill

will” of the insurer, while not a third element, “is probative of the second element . . . .”

Greene v. United Servs. Auto. Ass’n, 936 A.2d 1178, 1190–91 (Pa. Super. Ct. 2007)

(internal quotation marks omitted); see also Employers Mut. Cas. Co. v. Loos, 476 F.

Supp. 2d 478, 490–91 (W.D. Pa. 2007) (“[C]onsiderations of ‘the motive or self-interest or

ill will’ are probative with respect to a refusal to pay being frivolous or unfounded.”). The

“clear and convincing” standard requires the plaintiff to show the evidence is “‘so clear,

direct, weighty, and convincing as to enable the jury to come to a clear conviction, without

hesitancy, of the truth of the precise facts in issue.’” In re Estate of Fickert, 337 A.2d 592,

594 (Pa. 1975) (quoting La Rocca Trust, 192 A.2d 409, 413 (Pa. 1963)).

15
 An insurer owes a fiduciary duty to its insured and “must accord the interest of its

insured the same faithful consideration it gives its own interest.” Cowden, 134 A.2d at

228. The Pennsylvania Supreme Court explained this standard of care:

[W]hen there is little possibility of a verdict or settlement within the limits of
the policy, the decision to expose the insured to personal pecuniary loss must
be based on a bona fide belief by the insurer, predicated upon all of the
circumstances of the case, that it has a good possibility of winning the suit. .
. . Good faith requires that the chance of a finding of nonliability be real and
substantial and that the decision to litigate be made honestly.

Id. This standard “requires more than proof of sincerity; the evaluation of the case by the

insurance company must be honest, intelligent and objective.” Shearer v. Reed, 428 A.2d

635, 638 (Pa. Super. Ct. 1981) (citation and internal quotation marks omitted).

Section 8371 is not limited to an insurer’s bad faith denial of a claim. Pennsylvania

has recognized that an insured may recover against an insurer which, in bad faith, fails to

settle on the insured’s behalf. Birth Ctr. v. St. Paul Cos., Inc., 787 A.2d 376, 389–90 (Pa.

2001). A failure to settle will constitute bad faith if an insured has acted in its own self-

interest:

[T]here is an inherent conflict of interest between an insurance company and
its insured once an offer to settle within policy limits has been received.
Whenever the insurance company decides not to settle, it has, in effect,
chosen its interests over that of its insured’s . . . .

Shearer, 428 A.2d at 639.

Medical Protective contends there was no evidence of a demand or expressed

willingness to settle within policy limits on the part of Jurinko. The District Court

instructed the jury on this point according to Pennsylvania’s standard jury instructions:

16
“There must be an expressed willingness on the part of the third party, the plaintiff in the

underlying litigation, at some point in time, to accept an offer of policy limits.”10

Pennsylvania Suggested Standard Civil Jury Instructions § 13.21. Both parties submitted

this instruction. Dr. Marcincin’s policy limits, consisting of $200,000 of coverage under

10
We have found no case interpreting Pennsylvania law that has explicitly required an
“expressed willingness” on the part of a plaintiff to settle within the policy limits, despite
the language of the standard jury instructions. Some states have adopted a bright-line rule
in which a plaintiff must make a demand within policy limits in order for an insured to
have a claim of bad faith. See, e.g., Messersmith v. Mid-Century Ins. Co., 43 Ca. Rptr. 2d
871, 880 (Cal. Ct. App. 1995) (“Until the insurer is faced with a demand for policy limits,
it comes under no duty to evaluate the possibility of an excess judgment.”); Haddick ex
rel. Griffith v. Valor Ins., 763 N.E.2d 299, 304–05 (Ill. 2001) (“Since Illinois law
generally does not require an insurance provider to initiate settlement negotiations, this
duty . . . does not arise until a third party demands settlement within policy limits.”).
Other states do not require the insured to show it made a settlement offer within the
policy limits. See, e.g., Snowden ex rel. Estate of Snowden v. Lumbermens Mut. Cas. Co.,
358 F. Supp. 2d 1125, 1127–29 (N.D. Fla. 2003) (offer to settle by the claimant is not
necessary, but the “unwillingness of a victim to settle” is a defense, although the burden
of proof is on the insurer); Kingsley v. State Farm Mut. Auto. Ins. Co., 353 F. Supp. 2d
1242, 1248–52 (N.D. Ga. 2005) (finding, while it is unnecessary for a claimant to make a
policy limits offer, an insurer must be “on notice that it has an opportunity to settle”),
aff’d, 153 F. App’x 555 (11th Cir. 2005).
A bright-line rule requiring a demand within policy limits does not appear to
reflect Pennsylvania law or the realities of settlement negotiations. “The event
constituting breach of the fiduciary duty to handle settlement negotiations in good faith is
the refusal to accept a settlement offer which would be reasonably advantageous to the
insured in the light of all circumstances known at the time.” LaRocca v. State Farm Mut.
Auto. Ins. Co., 329 F. Supp. 163, 169 (W.D. Pa. 1971) (emphasis added); see also Puritan
Ins. Co. v. Canadian Universal Ins. Co., 775 F.2d 76, 82 (3d Cir. 1985) (“An insurance
carrier may be required to broach settlement negotiations under some circumstances . . .
.”). An insurer’s actions may arguably constitute bad faith whether a plaintiff makes a
demand within the policy limits or not. Here, we need not reach the question of whether
Pennsylvania law imposes a bright-line rule, as the court instructed the jury that an
expressed willingness to settle within the policy limits must be shown and the parties do
not challenge the instruction.

17
his policy with Medical Protective and $1 million with the CAT Fund, totaled $1.2

million. Frost, Jurinko’s attorney, made a demand of $1.1 million. Therefore, Jurinko

demonstrated “an expressed willingness” to settle within the policy limits.

The District Court found, and we agree, that the Jurinkos presented sufficient

evidence to find a bad faith failure to settle. Alff made it clear Medical Protective “did not

have a reasonable basis for” failing to settle “under the policy.” Terletsky, 649 A.2d at

688. He testified that Medical Protective’s refusal to offer more than $50,000 in a

settlement was a “negotiating tactic” — Alff thought by refusing to offer more money he

could force the CAT Fund to offer more from Dr. Edelman’s policy. This refusal

demonstrated an abandonment of the fiduciary duty Medical Protective owed to Dr.

Marcincin. Medical Protective acted in its own self-interest rather than in the interest of

Dr. Marcincin. Such negotiating tactics do not provide a reasonable basis for failing to

tender Dr. Marcincin’s policy limits.

Medical Protective “recklessly disregarded its lack of reasonable basis,” id., for

failing to tender the policy limits based on “motive[s] of self-interest,” Greene, 936 A.2d

at 1190. Two different judges put a settlement value on the case of at least $1.5 million,

and Alff believed the case was worth $750,000 but would likely settle for $1 million. The

CAT Fund’s letter informed Medical Protective it was acting in bad faith by failing to

tender policy limits. Medical Protective knew the CAT Fund, as Dr. Marcincin’s excess

insurer, could not offer any money on behalf of Dr. Marcincin in settlement unless

Medical Protective tendered its policy limits of $200,000.

18
 Medical Protective presented evidence showing it believed, going into the

underlying trial, that Dr. Marcincin was not liable. Kilcoyne hired a physician to examine

Jurinko’s medical records, who found no connection between the cancer on Jurinko’s nose

and the cancer on his neck. Nevertheless, the evidence still supported a claim for bad

faith. “[U]nder Pennsylvania law an insurer does not comply with the good faith standard

when it refuses to settle merely because it believes that its insured is not liable for the

claim asserted.” Haugh v. Allstate Ins. Co., 322 F.3d 227, 237 (3d Cir. 2003) (citing

Shearer, 428 A.2d at 638). Medical Protective cannot satisfy its duty of good faith

“merely by showing that it acted with sincerity.” Birth Ctr. v. St. Paul Cos., Inc., 727

A.2d 1144, 1156 (Pa. Super. Ct. 1999).

While the other parties — Jurinko, Dr. Marcincin, the CAT Fund, and SmithKline

— all were interested in reaching a settlement, Medical Protective would not budge from

its initial offer. All the parties, including Medical Protective, knew the case was worth far

more than $200,000, but Medical Protective refused to negotiate in good faith, instead

engaging in admittedly unfair negotiation tactics. Accordingly, we agree with the District

Court that there was sufficient evidence for the jury to find Medical Protective acted in

bad faith by failing to offer its policy limits in a settlement.

B. Bad Faith Representation

Medical Protective contests the finding of liability, contending the jury’s verdict

could have been based on a finding of bad faith in the representation of Dr. Marcincin and

not on a finding of bad faith failure to settle. See Carden v. Westinghouse Elec. Corp., 850

19
F.2d 996, 1000–06 (3d Cir. 1988) (requiring support for both grounds when a jury verdict

could be based on either of two theories). Medical Protective objects to the bad faith

representation ground by way of three challenges to the relevancy of expert Griffith’s

testimony about the conflict of interest: First, it argues an attorney conflict of interest

cannot support a claim under the Pennsylvania bad faith statute, and accordingly, the

expert testimony about the conflict of interest is irrelevant. Second, it contends no causal

connection exists between the conflict of interest and harm to Dr. Marcincin. Finally, it

asserts no evidence attributed Kilcoyne’s conduct to the insurer. Although Medical

Protective contested the relevancy of Griffith’s testimony in limine, its arguments have

changed during the course of the litigation, and we address whether they were properly

preserved.

A party failing to raise issues at trial cannot complain about them after trial. Wilson

v. Vt. Castings, Inc., 170 F.3d 391, 395 (3d Cir. 1999); Williams v. Runyon, 130 F.3d 568,

571–72 (3d Cir. 1997); see also Fed. R. Civ. P. 50 cmt. (2006) (“[T]he Rule 50(b) motion .

. . can be granted only on grounds advanced in the preverdict motion); Carden, 850 F.2d at

1001 n.5 (noting an objection at trial, preserving the issue for appeal). This requirement

“ensure[s] that both parties are aware of and can raise dispositive issues earlier in the

proceeding rather than later, so that the district court can resolve these issues correctly and

without delay.” Runyon, 130 F.3d at 572. Exceptions to this rule exist only to protect

against “fundamental and highly prejudicial error resulting in a miscarriage of justice.”

Wilson, 170 F.3d at 395–96 (citation and internal quotation marks omitted).

20
 Medical Protective’s motions before and during the trial did not raise the first11 or

second12 of the arguments it presses on appeal. Medical Protective did raise the third

argument, but the District Court resolved it correctly: Alff’s trial testimony provided

evidence from which the jury could find the insurer knew of and endorsed the conflict.

It may be disputed whether an attorney conflict of interest can support a claim

against an insurer under § 8371 — either as a matter of law or as a matter of fact in

particular cases — but the parties proceeded through trial assuming § 8371 provides a

cause of action for the conduct at issue here. Because Medical Protective did not contest

these issues in the District Court, we will not second guess the jury’s verdict on these

grounds. To do so would deprive Plaintiffs of timely, fair notice of the challenges to their

case, and it could require the expenditure of judicial resources that might have been

avoided by the presentation of additional evidence at trial, for example, or the use of a

11
Whatever its intent, Medical Protective did not raise the validity of § 8371 claims
based on attorney conflicts of interest with sufficient specificity: the District Court only
recognized an argument concerning relevancy conditioned on fact, not an argument
contesting the cognizability of the claim. Medical Protective could have raised the issue
again in its motion for judgment as a matter of law, but in that motion, it contested only
the sufficiency of the evidence for bad faith, and only for bad faith failure to tender policy
limits, not bad faith representation.
12
Both the motion in limine and the argument on appeal objected to Griffith’s
testimony, contending its relevancy was conditioned on facts not established. The motion
in limine, however, only purported to identify a lack of evidence establishing the insurer’s
knowledge or endorsement of the conflict of interest, not the lack of an evidentiary basis
establishing a causal connection between the conflict and harm to Dr. Marcincin. This
distinction is significant because evidence attributing knowledge of the conflict to the
insurer would differ from evidence establishing any harm the conflict caused.

21
special verdict form. See Runyon, 130 F.3d at 571–72. Moreover, we do not believe the

waiver results in a miscarriage of justice. Because Alff’s testimony established the factual

condition to which Medical Protective objected — the knowledge and endorsement of the

insurer — and because no other objections were properly raised, Griffith’s testimony

about the conflict of interest was relevant to the bad faith claim, as it was litigated, against

Medical Protective. Accordingly, we will affirm the jury’s finding of bad faith.

III.

A. Sufficiency of Evidence to Support Jury’s Punitive Damages Award

Medical Protective contends there was insufficient evidence for the jury to award

punitive damages. Punitive damages may be awarded in Pennsylvania “when the plaintiff

has established that the defendant has acted in an outrageous fashion due to either the

defendant’s evil motive or his reckless indifference to the rights of others.” Phillips v.

Cricket Lighters, 883 A.2d 439, 445 (Pa. 2005) (citation and internal quotation marks

omitted). “[T]he plaintiff must adduce evidence which goes beyond a showing of

negligence, evidence sufficient to establish that the defendant’s acts amounted to

‘intentional, willful, wanton or reckless conduct.’” Id. at 446 (quoting SHV Coal, Inc. v.

Cont’l Grain Co., 587 A.2d 702, 704 (Pa. 1991)). While a finding of bad faith may, by

itself, be sufficient to award punitive damages,13 the trial court gave Pennsylvania’s

13
The Superior Court of Pennsylvania has twice held “that a finding of bad faith
permits an award of punitive damages ‘without additional proof, subject to the trial
court’s exercise of discretion.’” Zimmerman v. Harleysville Mut. Ins. Co., 860 A.2d 167,
(continued...)

22
standard jury instruction on punitive damages. See Pennsylvania Suggested Standard Civil

Jury Instructions § 14.00. This instruction requires a showing of “outrageous” conduct.

Id.

There was sufficient evidence for the jury to find Medical Protective’s conduct

outrageous. Alff’s testimony demonstrates Medical Protective acted with bad motives, as

it “was trying to play a negotiating tactic against the CAT Fund” in order to save itself

money. Medical Protective recklessly exposed Dr. Marcincin to the risk of an excess

judgment despite knowing the case’s value far exceeded $200,000. These actions, along

with Alff’s appointment of Kilcoyne despite knowing of Kilcoyne’s conflict of interest,

and Alff’s failure to appoint separate counsel, constitute outrageous conduct.

B. Constitutionality of Punitive Damages Award

13
(...continued)
174 (Pa. Super. Ct. 2004) (quoting Hollock v. Erie Ins. Exch., 842 A.2d 409, 419 (Pa.
Super. Ct. 2004)); see also Thomas v. State Farm Ins. Co., 1999 WL 1018279, at *3 (E.D.
Pa. 1999) (“Reckless behavior sufficient to support a finding of bad faith under the
Terletsky test is thus also sufficient to impose punitive damages.” (citing Polselli v.
Nationwide Mut. Fire Ins. Co., 23 F.3d 747, 751 (3d Cir. 1994))). In Polselli, we found
“reckless behavior can constitute bad faith” but did not find that a finding of bad faith is
always sufficient to award punitive damages. 23 F.3d at 751.
Section 8371 appears to allow an award of punitive damages based on a finding of
bad faith: “In an action arising under an insurance policy, if the court finds that the
insurer has acted in bad faith towards the insured, the court may . . . [a]ward punitive
damages against the insurer.” 42 Pa. Cons. Stat. § 8371.
We need not predict how the Pennsylvania Supreme Court would rule on this
issue, however, as the District Court required the jury to make a finding of
outrageousness, and there is sufficient evidence to support that finding.

23
 Medical Protective contends the jury’s punitive damages award is

unconstitutionally excessive. We review the constitutionality of punitive damages de

novo. Cooper, 532 U.S. 424, 436 (2001). “Elementary notions of fairness enshrined in

our constitutional jurisprudence dictate that a person receive fair notice not only of the

conduct that will subject him to punishment, but also of the severity of the penalty that a

State may impose.” BMW of N. Am., Inc. v. Gore, 517 U.S. 559, 574 (1996). “The Due

Process Clause of the Fourteenth Amendment prohibits the imposition of grossly excessive

or arbitrary punishments on a tortfeasor.” State Farm Mut. Auto. Ins. Co. v. Campbell,

538 U.S. 408, 416 (2003). To determine whether an award is grossly excessive, the

Supreme Court has instructed us to look at three “guideposts”: “(1) the degree of

reprehensibility of the defendant’s misconduct; (2) the disparity between the actual or

potential harm suffered by the plaintiff and the punitive damages award; and (3) the

difference between the punitive damages awarded by the [factfinder] and the civil

penalties authorized or imposed in comparable cases.” Id. at 418.

1. Reprehensibility

“Perhaps the most important indicium of the reasonableness of a punitive damages

award is the degree of reprehensibility of the defendant’s conduct.” Gore, 517 U.S. at

575. We measure reprehensibility by considering whether

the harm caused was physical as opposed to economic; the tortious conduct
evinced an indifference to or a reckless disregard of the health or safety of
others; the target of the conduct had financial vulnerability; the conduct
involved repeated actions or was an isolated incident; and the harm was the
result of intentional malice, trickery, or deceit, or mere accident.

24
Campbell, 538 U.S. at 419.

With respect to the first and second subfactors, there is no evidence that Dr.

Marcincin suffered physical harm or that Medical Protective’s conduct “evinced an

indifference to or a reckless disregard of the health or safety of others.” Id. The Jurinkos

contend Dr. Marcincin suffered physical harm because he underwent a lengthy trial and

suffered embarrassment in his community, but these facts do not constitute physical harm.

The District Court found the last three subfactors relevant to Medical Protective’s

conduct. The court correctly found Dr. Marcincin financially vulnerable because he would

be forced to deplete his life savings to pay the excess judgment.14 The court found

Medical Protective was a recidivist based on (1) its repeated refusal to tender its policy

during settlement negotiations despite strong indications that Dr. Marcincin’s liability

exceeded policy limits, and (2) its assignment of Kilcoyne as counsel. The Supreme Court

has examined a defendant’s recidivist behavior as it relates to non-parties, not to plaintiffs.

See Gore, 517 U.S. at 577–79 (defendant’s selling of repainted cars as “new” to 1,000

people was considered recidivist conduct). The Court has not considered whether the

conduct at issue in a single case can also demonstrate a defendant’s recidivism. We have

found such conduct “to be relevant, but with less force.” Willow Inn, Inc. v. Pub. Serv.

14
For purposes of determining Dr. Marcincin’s financial vulnerability, it is irrelevant
that Dr. Marcincin was able to assign his bad faith claim to the Jurinkos to avoid paying
the excess judgment. Medical Protective acted as it did knowing of Dr. Marcincin’s
financial vulnerability, and with no knowledge that an assignment of the bad faith claim
would save him from financial difficulty.

25
Mut. Ins. Co., 399 F.3d 224, 232 (3d Cir. 2005); see also Williams v. Conagra Poultry Co.,

378 F.3d 790, 798 (8th Cir. 2004) (considering plaintiff’s testimony concerning instances

in which he experienced racism when looking at defendant’s recidivist behavior). But see

Bridgeport Music, Inc. v. Justin Combs Publ’g, 507 F.3d 470, 487 (6th Cir. 2007) (“The

repeated conduct factor requires that the similar reprehensible conduct be committed

against various different parties rather than repeated reprehensible acts within the single

transaction with the plaintiff.” (citation and internal quotation marks omitted)). There is

no evidence that Medical Protective exhibited similar behavior toward other insureds, so

any evidence of recidivism will be given less force. Willow Inn, 399 F.3d at 232. The

record reveals one instance where Medical Protective appointed an attorney with a conflict

of interest and several instances where it refused to tender its policy limits during the

course of settlement negotiations.

Any evidence of recidivism is limited to the case before us. The conduct in Willow

Inn provides more compelling evidence of recidivism. Willow Inn brought a property

damage claim after the Inn was damaged by a tornado. Id. at 227. The insurer, Public

Service Mutual Insurance Company (“PSM”), continually delayed the process by, for

instance, delaying the hiring of an appraiser until eight months after Willow Inn’s initial

appraisal request, failing to respond to its own adjuster’s correspondence for months, and

failing to acknowledge Willow Inn’s request for payment for costs incurred repairing a

leaky roof despite its clear entitlement to such payments. Id. at 227–28, 232. Willow Inn

26
did not recover full payment until two years after the claim was made. Id. at 228. The

district court found bad faith on the part of PSM:

“[U]nreasonable delays in the processing of the Willow Inn’s claims were
extraordinarily unwarranted such that there can be no conclusion except that
PSM knowingly or recklessly disregarded the absence of a reasonable basis
for its conduct. The record is replete with examples of PSM’s failure to
respond in a timely fashion to Willow Inn’s various reasonable requests, and
even to the requests of those working on PSM’s behalf.”

Id. at 229 (quoting the district court). PSM’s repeated delay caused increasing harm to

Willow Inn, which needed payment of the claim to repair the property damage. But here

delays caused Dr. Marcincin no harm. Although Medical Protective’s failure to settle

ultimately amounted to bad faith, initial refusals to settle at a certain amount during the

course of settlement negotiations do not demonstrate recividism. Therefore, the recidivism

subfactor points only minimally, if at all, in the Jurinkos’ favor.

The harm Dr. Marcincin suffered was the result of Medical Protective’s intentional

conduct, not accident. Alff knew his appointment of Kilcoyne to represent both

physicians would create a conflict of interest. He also testified that he intentionally

refused to tender Dr. Marcincin’s policy in order to force the CAT Fund to pay more from

Dr. Edelman’s policy. Medical Protective’s bad faith conduct was intentional, and Dr.

Marcincin was financially vulnerable. But there is no evidence of the first two factors and

scant evidence of recidivism.

2. Ratio Between Harm and Punitive Damages Award

27
 While we cannot “‘draw a mathematical bright line between the constitutionally

acceptable and constitutionally unacceptable [award], . . . [a] general concer[n] of

reasonableness . . . properly enter[s] into the constitutional calculus.’” Gore, 517 U.S. at

583 (quoting Pac. Mut. Life Ins. Co. v. Haslip, 499 U.S. 1, 18 (1991)). The Supreme

Court has set forth instructive principles. First, “few awards exceeding a single-digit ratio

between punitive and compensatory damages, to a significant degree, will satisfy due

process.” Campbell, 538 U.S. at 425. Second, “an award of more than four times the

amount of compensatory damages might be close to the line of constitutional impropriety.”

Id. (citing Haslip, 499 U.S. at 23–24). Third, “[w]hen compensatory damages are

substantial, then a lesser ratio, perhaps only equal to compensatory damages, can reach the

outermost limit of the due process guarantee.”15 Id. While helpful, “[t]hese statements do

not compel a particular result in this case, as they are not holdings of the Court.” Bach v.

First Union Nat’l Bank, 486 F.3d 150, 156 (6th Cir. 2007). “The precise award in any

case . . . must be based upon the facts and circumstances of the defendant’s conduct and

the harm to the plaintiff.” Campbell, 538 U.S. at 425.

15
The Supreme Court recently found that a punitive damages award may not exceed a
1:1 ratio in the context of maritime law. Exxon Shipping Co. v. Baker, 128 S. Ct. 2605,
2633 (2008). The Court did not directly address constitutional limits. See id. at 2626
(“[W]e are reviewing a jury award for conformity with maritime law, rather than the outer
limit allowed by due process; we are examining the verdict in the exercise of federal
maritime common law authority, which precedes and should obviate any application of
the constitutional standard.”). However, the Court again said that, when punitive
damages are substantial, “the constitutional outer limit may well be 1:1.” Id. at 2634
n.28.

28
 Here, the ratio is 3.13:1.16 High ratios do not violate due process if “a particularly

egregious act has resulted in only a small amount of economic damages,” or if “the injury

is hard to detect or the monetary value of noneconomic harm might have been difficult to

determine.” Id. (quoting Gore, 517 U.S. at 582). Here the compensatory damages are

substantial, Dr. Marcincin suffered only economic harm, and the harm was easily

measured — it was the amount of the excess judgment. See id. Medical Protective’s acts

were egregious, but not likely “particularly” egregious. Campbell counsels, under these

circumstances, that only a lesser award satisfies due process. Id.

Other courts have used a 1:1 ratio as a benchmark where compensatory damages

are substantial. See Bridgeport Music, Inc., 507 F.3d at 488, 490 (“[A] ratio of closer to

1:1 or 2:1 is all that due process can tolerate” where the compensatory damages award was

already substantial — $366,939 — and the original award had a ratio of 9.5:1); Williams v.

Conagra Poultry Co., 378 F.3d 790, 796–99 (8th Cir. 2004) (reduced punitive damages

award from an approximately 10:1 ratio to a 1:1 ratio because plaintiff received substantial

compensatory damages — $600,000); Slip-N-Slide Records, Inc. v. TVT Records, LLC,

No. 05-21113-CIV, 2007 WL 3232274, at *30 (S.D.Fla. Oct. 31, 2007) (affirming a

16
In calculating this ratio, we include attorneys’ fees and costs as part of compensatory
damages. In Willow Inn, we found the Pennsylvania Supreme Court would adopt the
view of the Superior Court in Hollock v. Erie Ins. Exch., 842 A.2d 409 (Pa. Super. Ct.
2004) (en banc), which considered attorneys’ fees and costs awarded pursuant to § 8371
for purposes of calculating the ratio. Willow Inn, 399 F.3d at 236; see also Action
Marine, Inc. v. Cont’l Carbon, Inc., 481 F.3d 1302, 1321 (11th Cir. 2007) (“In Georgia,
awards of attorney fees in tort cases involving bad faith are compensatory in nature.”).

29
punitive damages award, which had been reduced to reflect a 1:1 ratio by the District

Court, because the “substantial [compensatory damages award of $2.3 million] mitigates

against a punitive damages award that materially exceeds that same amount”); Zakre v.

Norddeutsche Landesbank Girozentrale, 2008 WL 351662, at *7 (S.D.N.Y. Feb. 8, 2008)

(reducing a punitive damages award, where the ratio was 2:1, because compensatory

damages were substantial — $1.65 million); Thomas v. Istar Fin., Inc., 508 F. Supp. 2d

252, 263 (S.D.N.Y. 2007) (“[T]he Court believes the [3:1 to 4:1] ratio in this case is

excessive because Thomas was awarded a very substantial amount in compensatory

damages [$443,500], making a punitive award equal to the compensatory damage award

more appropriate.”); see also, Action Marine, Inc., 481 F.3d at 1317–23 (affirming a

punitive damages award with a 5:1 ratio, based on a $3.2 compensatory damage award, in

which there was physical, not just economic harm, as well as harm to many non-parties).

In Boerner v. Brown & Williamson Tobacco Co., 394 F.3d 594 (8th Cir. 2005), a jury

awarded $4.025 million in compensatory damages and $15 million in punitive damages in

favor of a smoker’s husband, who sued Brown & Williamson Tobacco for a design defect

in its product. Id. at 598. The Eighth Circuit reduced the punitive damages award to $5

million, approximately a 1:1 ratio. Id. at 602–04. The court found, despite a strong

showing of reprehensibility, that the 3:1 ratio was “excessive when measured against the

substantial compensatory damages.” Id. at 603. There, the factors that justify a higher

ratio were absent — those same factors are absent here. Id. The court said, “despite

evidence that [the defendant] exhibited a callous disregard for the adverse health

30
consequences of smoking, there is no evidence that anyone at American Tobacco intended

to victimize its customers.” Id. Similarly, Medical Protective demonstrated bad faith by

failing to act in Dr. Marcincin’s best interests, but the evidence does not show it intended

to victimize him. In light of the substantial compensatory award and the harm being

exclusively economic, this guidepost advises a reduced award.

3. Disparity Between Punitive Damages Award and Civil Penalties

“Comparing the punitive damages award and the civil or criminal penalties that

could be imposed for comparable misconduct provides a third indicium of excessiveness.”

Gore, 517 U.S. at 583. This guidepost, which “should accord substantial deference to

legislative judgments concerning appropriate sanctions for the conduct at issue,” id.,

“provides notice of possible sanctions to potential violators,” Willow Inn, 399 F.3d at 237.

The District Court relied on Willow Inn, in which we upheld a punitive damages award

where the insurer’s bad faith conduct “arguably amounted to multiple violations of 40 Pa.

Stat. Ann. § 1171 [of Pennsylvania’s Unfair Insurance Practices Act (“UIPA”)].” Id. at

237–38. The UIPA “regulate[s] trade practices in the business of insurance” by setting

forth the unfair or deceptive practices prohibited in Pennsylvania. 40 Pa. Stat. Ann. §

1171.2. The Commissioner may seek a penalty of up to $5,000 for each violation of the

UIPA. Id. § 1171.11(1). The Commissioner may also suspend or revoke the offender’s

license. Id. § 1171.9. Section 1171.5(a) sets forth two relevant “unfair or deceptive acts

or practices” punishable by fine or suspension or revocation of the insurer’s license:

31
 (vi) Not attempting in good faith to effectuate prompt, fair and equitable
settlements of claims in which the company’s liability under the policy has
become reasonably clear.

(xiii) Failing to promptly settle claims, where liability has become
reasonably clear, under one portion of the insurance policy coverage in order
to influence settlements under other portions of the insurance policy
coverage or under other policies of insurance.

Id. § 1171.5(a)(10)(vi), (xiii). In Willow Inn, we did not overturn the punitive damages

award despite punitive damages outnumbering the civil penalty 30:1. Willow Inn, 399

F.3d at 237–38. We were unwilling to overturn the award solely based on this third

guidepost because we were “unsure as to how to properly apply” it. Id. at 238.

Furthermore, the insurer’s conduct could have amounted to multiple violations of § 1171,

which could also have led to suspension and revocation of one’s license to issue insurance

policies. Id.

Section 1171 provides notice to violators of possible sanctions. It also reveals a

substantial disparity between the punitive damages award and the civil penalty. While we

found the 30:1 disparity in Willow Inn insufficient to overturn the punitive damages award

in light of the confusion surrounding this guidepost, we face a disparity here of 1250:1.

While courts do not focus on the ratio under this factor, the District Court failed to

consider that, although the award in Willow Inn was $150,000, the award here is $6.25

million, putting a discussion of civil penalties on a different footing. In Gore, the Supreme

Court said a statute imposing sanctions of up to $10,000 for deceptive trade practices

could not provide a potential offender notice that it might be subject to a multimillion

32
dollar penalty. Gore, 517 U.S. at 584. While the potential exists for a suspension or

revocation of Medical Protective’s license to sell insurance, the large punitive damages

award appears excessive in light of the comparatively modest monetary sanctions imposed

for such conduct. Section 1171 is unlikely to provide an insurer with fair notice of a $6.25

million award. Although the outrageous conduct that occurred here is unlikely to be

deterred by the statutory penalties in § 1171, the third guidepost suggests the award was

excessive.

4. Conclusion

Consideration of the guidelines leads us to conclude that the punitive damages

award should be reduced. Medical Protective’s conduct does not justify so high an award

in light of the moderate degree of reprehensibility, the substantial compensatory award,

and the large disparity between the award and civil penalties under § 1171. Only two of

the reprehensibility factors point strongly toward reprehensible conduct, because little, if

any, evidence of recidivism exists. With regard to the proper ratio, the Supreme Court has

instructed that “[w]hen compensatory damages are substantial, then a lesser ratio, perhaps

only equal to compensatory damages, can reach the outermost limit of the due process

guarantee.” Campbell, 538 U.S. at 425. We believe, in light of our consideration of all

three guideposts, the Supreme Court’s statement instructs the outcome here. Accordingly,

we will reduce the award to reflect a 1:1 ratio.

IV.

33
 The Jurinkos appeal the order of the District Court, which granted in part and

denied in part the Jurinkos’ motion to mold the verdict. First, the Jurinkos contend the

District Court erred by refusing to award bad faith interest under § 8371. Second, they

contend the District Court erred by using the lodestar method rather than the percentage-

of-recovery method to calculate attorneys’ fees. Because the District Court properly found

the Jurinkos waived their right to bad faith interest, and because the District Court

properly used the lodestar method to calculate attorneys’ fees, we will affirm.

A. Bad Faith Interest

Section 8371 permits courts to “[a]ward interest on the amount of the claim from

the date the claim was made by the insured in an amount equal to the prime rate of interest

plus 3%.” 42 Pa. Cons. Stat. § 8371(1). “If the correct legal standards are applied and the

findings of fact are not clearly erroneous, the reasonableness of a fee award is reviewed

only for abuse of discretion.” Polselli v. Nationwide Mut. Fire Ins. Co., 126 F.3d 524, 533

n.11 (3d Cir. 1997). The District Court instructed the jury on a stipulation reached by the

parties with regard to compensatory damages: “The financial losses include the portion of

the $2.5 million verdict that exceeded Dr. Marcincin’s insurance coverage, together with

delay damages and interest on that amount, for a total of $1,658,345.” The post-judgment

interest from this stipulation amounted to $286,315.22. It was calculated at a rate of 6

percent simple interest, accruing from April 26, 2002, to October, 18, 2005, on the

$1,372,030.04 excess verdict. The District Court found, because the parties stipulated to

34
an award of interest during trial, the Jurinkos waived their ability to recover statutory

interest under § 8371(1).

The Jurinkos contend they did not waive their right to interest equal to prime plus

3%. The Jurinkos point to the following exchange during the bad faith trial regarding the

stipulation and post-judgment interest:

Mr. Tanner [Jurinkos’ counsel]: And similarly, the statutory provision again
under 8371 that reflects the amount of interest to be added to any award
would also be something that the Court could calculate. And we would do
that by way of post-trial motion, in the event we are successful.

Mr. Lerman [Medical Protective’s counsel]: And our pretrial statement
reflects that we agree to that also, Your Honor.

The Court: Very well.

But this statement can be read consistently with the stipulated compensatory damages and

the additional interest the District Court awarded upon the Jurinkos’ post-trial motion to

mold the verdict. The stipulated compensatory damages included an award of interest

based on the amount of the excess verdict ($1.3 million) and delay damages ($72,030.04).

The interest was calculated from April 26, 2002, the date of the excess verdict, to October

18, 2005, at a rate of six percent. In its order granting in part the Jurinkos’ motion to mold

the verdict, the District Court awarded interest from October 19, 2005, through the date of

the order, at a rate of prime plus three percent under § 8371(1).

That the Jurinkos waived their right to additional interest is made clear by their

calculation of interest. In order to award interest under § 8371, the Jurinkos ask us to

award interest at prime plus three percent, then subtract any interest already recovered as

35
part of the compensatory award. The interest awarded in the compensatory award was

intended to comprise all of the interest the Jurinkos were entitled to for the period of April

26, 2002, through October 18, 2005, with the Jurinkos free to move for additional interest

based on the period following October 18, 2005. The District Court, in its discretion,

awarded interest at prime plus three percent for the period from October 19, 2005, through

the date of the order. We have explained that, in the context of § 8371, interest is awarded

“to make the successful plaintiff completely whole.” Klinger v. State Farm Mut. Auto. Ins.

Co., 115 F.3d 230, 236 (3d Cir. 1997). By stipulation, the parties determined what amount

would make Dr. Marcincin whole. The Jurinkos are therefore not entitled to additional

interest beyond that already awarded.

B. Attorneys’ Fees

Section 8371 also permits a court to “[a]ssess court costs and attorney fees against

the insurer.” 42 Pa. Cons. Stat. § 8371(3); Polselli, 126 F.3d at 529, 533–34. “The

question of what standard to apply in calculating attorney’s fees and costs is a legal

question and is subject to plenary review.” Polselli, 126 F.3d at 533. “If the correct legal

standards are applied and the findings of fact are not clearly erroneous, the reasonableness

of a fee award is reviewed only for abuse of discretion.” Id. at 533 n.11. As with

awarding interest, attorneys’ fees are awarded to make the plaintiff whole. Klinger, 115

F.3d at 236.

In its motion to mold the verdict, the Jurinkos requested $2,372,503.50 in attorneys’

fees — thirty percent of the verdict. This amount reflects the Jurinkos’ contingency fee

36
agreement with their counsel and is calculated according to the percentage-of-recovery

method, which awards fees as a fixed portion of the verdict. The Jurinkos contend courts

may choose between the percentage-of-recovery method or the lodestar method. We have

predicted how the Pennsylvania Supreme Court would calculate attorneys’ fees in bad

faith insurance claims. In Polselli, we determined a trial court must consider the factors

set forth in Pennsylvania Rule of Civil Procedure 1716. Polselli, 126 F.3d at 534. 17

While the Pennsylvania Supreme Court has not addressed this issue, the Pennsylvania

Superior Court adopted this approach. See Birth Ctr., 727 A.2d at 1160. A calculation of

attorneys’ fees under Rule 1716 begins with the lodestar method. Id.

The Jurinkos cite to common fund cases for the proposition that we should adopt

the percentage-of-recovery method. See, e.g., In re Prudential Ins. Co. of Am. Sales

Practices Litig., 148 F.3d 283, 333 (3d Cir. 1998). Prudential Insurance Co. sets out

when each method is appropriate:

The percentage-of-recovery method is generally favored in cases involving a
common fund, and is designed to allow courts to award fees from the fund in
a manner that rewards counsel for success and penalizes it for failure. The
lodestar method is more commonly applied in statutory fee-shifting cases,

17
Rule 1716 requires a court, which is entitled to award attorneys’ fees, to consider the
following factors:
(1) the time and effort reasonably expended by the attorney in the litigation;
(2) the quality of the services rendered;
(3) the results achieved and benefits conferred upon the class or upon the
public;
(4) the magnitude, complexity and uniqueness of the litigation; and
(5) whether the receipt of a fee was contingent on success.
Pa. R. Civ. P. 1716.

37
 and is designed to reward counsel for undertaking socially beneficial
litigation in cases where the expected relief has a small enough monetary
value that a percentage-of-recovery method would provide inadequate
compensation.

Id. (internal citations and quotations omitted). Section 8371 is a fee-shifting statute.

Therefore, the use of the lodestar method is appropriate. This conclusion is supported by

the fact that no court has adopted the percentage-of-recovery method to calculate

attorneys’ fees under § 8371.

The Jurinkos contend that use of the lodestar method requires creating “a fictional

scenario whereby an attorneys’ fee is calculated based upon an hourly rate in a bad faith

case” when, in fact, most attorneys undertake a bad faith case on a contingency fee.

Jurinkos’ Br. at 76. But Rule 1716 allows courts to consider whether a “contingency

enhancement” is appropriate based on the facts of a given case. Polselli, 126 F.3d at

535–36; Birth Ctr., 727 A.2d at 1161. In fact, the District Court examined whether a

contingent risk required an enhancement of the lodestar amount. The court found any risk

of contingency — based on the complexity of the case, for example — was “reflected in

the overall hours worked and rates charged by Plaintiffs’ attorneys.” Because courts

consider the increased risk of contingency fees under Rule 1716, its use here is both fair

and appropriate.

For these reasons, Rule 1716 governs the calculation of attorneys’ fees in a § 8371

case. The District Court did not err by adopting Rule 1716 and the lodestar method to

calculate attorneys’ fees. The Jurinkos do not contend the District Court improperly

38
calculated attorneys’ fees under the lodestar method. Regardless, “the determination of a

reasonable fee is an inherently case-specific endeavor,” Polselli, 126 F.3d at 535–36, and

the District Court did not abuse its discretion in calculating the appropriate fee.

V.

Accordingly, we will affirm the judgment entered on the verdict and, because we

find the punitive damages award unconstitutionally excessive, reduce the punitive

damages award to $1,996,950.56. We will also affirm the District Court’s order affirming

in part and denying in part the Jurinkos’ motion to mold the verdict.

39